With its shares near their 52-week low thanks to weak earnings and fears of medical research...

|By:, SA News Editor

With its shares near their 52-week low thanks to weak earnings and fears of medical research spending cuts, Thermo Fisher Scientific (TMO) has authorized a new $750M stock buyback plan, good for over 4% of outstanding shares at their current price. The lab equipment maker has only $25M left on an existing authorization.